1. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities

   • Disha D. Shah
   • Bhavarth P. Dave
   • Manish P. Patel

   Review Article 21 January 2023 Article: 84

   

2. Correction to: The natural medicinal fungus Huaier promotes the anti‑hepatoma efficacy of sorafenib through the mammalian target of rapamycin‑mediated autophagic cell death

   • Zhengguang Zhang
   • Cunsi Shen
   • Fuqiong Zhou

   Correction 21 January 2023 Article: 83

   

3. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics

   • Subhasmita Bhal
   • Chanakya Nath Kundu

   Review Article 20 January 2023 Article: 82

   

4. Molecular and therapeutic effect of CRISPR in treating cancer

   • Sawani Rodrigo
   • Kaveesha Senasinghe
   • Sameer Quazi

   Review Article Open access 17 January 2023 Article: 81

   

5. Polymorphic renal transporters and cisplatin’s toxicity in urinary bladder cancer patients: current perspectives and future directions

   • Mohamed S. Selim
   • Amira B. Kassem
   • Marwa Samir Hamza

   Review Article Open access 17 January 2023 Article: 80

   

6. PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer

   • Xiaoxiao Liu
   • Muli Xu
   • Wenlin Tai

   Original Paper 17 January 2023 Article: 79

   

7. Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer

   • Chen Wang
   • Rui Bai
   • Ping Yang

   Original Paper 12 January 2023 Article: 78

   

8. A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

   • Yan Wei
   • Lijun Wang
   • Chunji Gao

   Original Paper Open access 10 January 2023 Article: 77

   

9. SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway

   • Ying Wang
   • Xia Luo
   • Jing Wang

   Original Paper Open access 10 January 2023 Article: 76

   

10. Metabolomic profiling identifies hair as a robust biological sample for identifying women with cervical cancer

    • Rui Ran
    • Xiaocui Zhong
    • Ting-Li Han

    Original Paper 07 January 2023 Article: 75

    

11. Breast tumor metastasis following filgrastim administration due to the SDF-1/CXCR4 pathway

    • Solmaz Khalighfard
    • Vahid Khori
    • Ali Mohammad Alizadeh

    Original Paper 06 January 2023 Article: 74

    

12. Downregulation of CEMIP enhances radiosensitivity by promoting DNA damage and apoptosis in colorectal cancer

    • Jiawen Weng
    • Yuqin Zhang
    • Yiyi Li

    Original Paper 06 January 2023 Article: 73

    

13. Iodine-125 brachytherapy suppresses tumor growth and alters bone metabolism in a H1299 xenograft mouse model

    • Jiangtao Bai
    • Qiquan Yu
    • Guoying Zhu

    Original Paper 06 January 2023 Article: 72

    

14. DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective

    • Sannidhi Bhootra
    • Nandana Jill
    • Koustav Sarkar

    Review Article 05 January 2023 Article: 71

    

15. P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway

    • Zhechuan Zhang
    • Yuanfeng Zhang
    • Ronggui Zhang

    Original Paper 02 January 2023 Article: 70

    

16. FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes

    • Danmei Sheng
    • Beiling Chen
    • Yaacov Ben-David

    Original Paper 31 December 2022 Article: 69

    

17. Sensitization of cervical cancer cells to radiation by the cyclin-dependent kinase inhibitor dinaciclib

    • Haichen Zhang
    • Tong Chu
    • Haidong Zhao

    Original Paper 31 December 2022 Article: 68